Technavio, a tech-focused market research firm, has published a new report on the global anesthesia drugs market, which is expected to grow at a CAGR of close to 3% during the forecast period 2017-2021.
Based on geographical segmentation, Technavio market researchers categorize the global anesthesia drugs market into the following key regions: the Americas, APAC, and EMEA.
Source: Technavio
Click here to request a free sample of this report
Anesthesia drugs market in the Americas: The growing incidence of several conditions such as chronic respiratory disorders and cardiovascular disorders is anticipated to drive the adoption rates of anesthesia drugs in the Americas. Besides, the increasing surgical procedures have driven the demand for anesthesia, thereby contributing to the growth of the market.
According to Sapna Jha, a lead analyst at Technavio, specializing in research on orthopedics and medical devices, “Increasing demand for propofol is expected to drive the market growth in the US, owing to its rapid onset of action than other conventional anesthetics. Besides, the growing focus of vendors to explore new routes of administration such as oral and topical will further drive the market growth.”
Anesthesia drugs market in EMEA: Rising awareness and established healthcare infrastructure in Europe has led to the high demand for anesthesia drugs such as propofol in a new route of administration. The developed economies in Europe are witnessing robust demand for intravenous and topical anesthetics owing to increased need for effective treatments. Increasing demand of anesthesia drugs in outpatient surgeries will fuel the adoption of regional and local anesthetics in EMEA. Furthermore, growing focus of vendors toward the development of effective anesthesia drugs for pediatrics will fuel the market growth during the forecast period.
Anesthesia drugs market in APAC: The region is expected to witness the faster growth due to the rising number of surgical procedures, which is contributing to the rise in growth of the anesthesia drugs market in APAC. Growing awareness among physicians about novel routes of administration will bring substantial growth opportunities in APAC. Moreover, increasing demand for anesthesia drugs in the dental application is expected to fuel the market growth.
Ask an analyst to know more about this report
The top vendors operating in the global anesthesia drugs market are:
- AbbVie
- Aspen
- Baxter
- B. Braun
- Fresenius Kabi
Other prominent vendors in the market include Air Liquide, Arbor Pharmaceuticals, Avera Pharmaceuticals, Eisai, GSK, Jiangsu HengRui Medicine, Johnson & Johnson, Lannett Company, Merck, Mydent International, Novalar Pharma, Nuvo Pharmaceuticals, Paion UK, Pfizer, Primex Pharmaceuticals, St. Renatus, Takeda, and The Medicines Company.
A more detailed analysis is available in the Technavio report titled, ‘Global Anesthesia Drugs Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global Breast Biopsy Market 2017-2021
- Global Neuroendovascular Non-Coils Market 2016-2020
- Global Deep Brain Stimulation Market 2016-2020
To read more press releases – click here
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
https://www.technavio.com/
